Basecamp
Founded 2019 · 73 employees on LinkedIn · 15 known investors
A new type of biodiscovery, discovering and harnessing nature's most valuable proteins
Also known as Basecamp Research · BCR
Founders & leadership
Basecamp was founded in 2019 by Oliver Vince and Glen Gowers.
Investors · 15
Also in the syndicate · 3
Company profile
researched Aug 2026Basecamp Research is a UK-based company that applies artificial intelligence to biological systems design, positioning its work as exploring biology beyond what is captured in existing public reference databases. It collects biodiversity-derived genetic data and organises it into a proprietary foundational dataset and knowledge graph, which it uses to identify and refine novel proteins matched to specific applications for partner organisations.
The company's product framework, BaseGraph, is described as a generation of AI-based design built on a high-resolution map of global genetic biodiversity. By capturing the genetic, evolutionary and environmental context of each protein, the company states it can design proteins tailored to particular industrial, therapeutic or diagnostic uses without running directed evolution campaigns. Its stated commercial focus is business-to-business work with partners in the biopharma and wider bioscience ecosystem rather than public-facing products.
Founding story
Basecamp Research was founded in the United Kingdom by Glen Gowers and Oliver Vince. Gowers serves as co-founder and CEO.
Business model
The company works through commercial bioscience partnerships, applying its dataset and AI design capabilities to identify and optimise proteins for partners' specified industrial, therapeutic and diagnostic applications.
Traction
As of October 2024 the company reported 15 commercial bioscience partnerships across a range of industries and total funding of $85 million.
Latest developments
In October 2024 Basecamp Research announced a $60 million Series B led by Singular, appointed biotech executive Anupama Hoey as Chief Commercial Officer, and entered a multi-year collaboration with the laboratory of David R. Liu at the Broad Institute of MIT and Harvard focused on approaches to programmable genetic medicines.
▸Full profile — market position, technology, go-to-market, geography
Market position
The company is described in press coverage as a participant in mapping biodiversity for AI-based design of biological systems, with its approach compared to protein-structure work such as DeepMind's AlphaFold 2.
Technology
Basecamp Research builds a foundational biological dataset reported to contain 100 times more advanced biological systems than the public databases most commonly used by pharmaceutical researchers. This underpins BaseGraph, a knowledge graph and AI design system built on a high-resolution map of global genetic biodiversity. Capturing the genetic, evolutionary and environmental context of each protein is presented as the basis for designing application-specific proteins without directed evolution campaigns. Proceeds from the 2024 Series B were earmarked for scaling data collection, expanding computing capacity and developing a further generation of foundational models.
Go-to-market
Partners in biopharma and other bioscience-adjacent industries seeking proteins for industrial, therapeutic or diagnostic applications.
Geography
Founded and based in the United Kingdom.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 1
by search overlapCompanies competing with Basecamp for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 3
launches, deals, and filingsThe company secured a $60 million Series B financing led by Singular, with S32, redalpine, André Hoffmann, Feike Sijbesma, Paul Polman and returning investors True Ventures and Hummingbird Ventures participating. Proceeds are directed to scaling data collection, computing and new foundational models.
$60M source ↗
The company added biotech executive Anupama Hoey as Chief Commercial Officer, reported with more than 20 years of leadership experience and biopharma deals worth more than $5 billion.
Basecamp Research entered a multi-year collaboration with the laboratory of Dr. David R. Liu at the Broad Institute of MIT and Harvard to advance approaches to programmable genetic medicines.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Basecampbasecamp-research.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Basecamp do?
- Basecamp Research is a UK AI biotech mapping global genetic biodiversity to design proteins for industrial, therapeutic and diagnostic uses.
- Who founded Basecamp?
- Basecamp was founded by Oliver Vince, Glen Gowers in 2019.
- Who are Basecamp's investors?
- Basecamp's investors include Blue Horizon Corporation, Hummingbird Ventures, NVentures, S32, Section 32, Systemiq Capital, True Ventures, Valo Ventures and 4 more.